Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs

[Marketwired] – Horizon Pharma, Inc., , a commercial stage, specialty pharmaceutical company that markets two gastroprotective nonsteroidal anti-inflammatory drugs , VIMOVO® and DUEXIS® , announced that the FDA joint … more

View todays social media effects on HZNP

View the latest stocks trending across Twitter. Click to view dashboard

See who Horizon is hiring next, click here to view